Amgen announced it will present at the 2026 Wells Fargo Healthcare Conference on September 10, 2026, featuring top executives including CFO Thomas Dittrich and Chief Medical Officer Paul Burton. The presentation will be webcast live and available for replay for 90 days on Amgen's website, providing investors and the public access to updates on the company's business and pipeline. Amgen is a leading biotech firm known for innovative medicines targeting cancer, heart disease, and other serious conditions, and is part of major stock indices like the Dow Jones Industrial Average and Nasdaq-100. This event offers insight into Amgen's ongoing developments and strategic direction.
Amgen will hold a webcast on October 24, 2026, during the European Society of Medical Oncology Congress (ESMO) to discuss its oncology portfolio and present selected data. The event will feature senior executives including Murdo Gordon and Jean-Charl...
Eli Lilly's stock rose 4% following a positive recommendation from the European Medicines Agency for its oral obesity pill, Foundayo, which is now close to final approval in the EU. This pill offers dosing flexibility and treats both weight managemen...
Amgen and AstraZeneca announced positive Phase 3 CROSSING trial results for TEZSPIRE (tezepelumab-ekko), demonstrating significant and lasting improvements in patients with eosinophilic esophagitis (EoE). The drug achieved histologic remission in abo...
